MirZyme Therapeutics, a UK-based biotechnology company focused on transforming maternal health, today announced the appointment of Lindsey Carnett, CEO and President of Marketing Maven Public Relations, Inc., as Global Ambassador for Women’s Health Innovation in the United States. In this role, Carnett will support MirZyme’s mission to make preeclampsia predictable and treatable through strategic introductions, advocacy, and engagement with healthcare institutions, women’s he

BIRMINGHAM, UK – 11 December 2025 – MirZyme Therapeutics, a UK-based, clinical stage biotechnology company developing diagnostic and therapeutic solutions for preeclampsia, has been named the winner of the 2025 Institute of Physics (IOP) Business Start-Up Award. The award recognises companies applying physics and biophysics to deliver commercially scalable technologies with significant real-world impact. The IOP Business Awards are the Institute’s highest industry honour, awa

Every life saved begins with early detection. MPREG® empowers timely intervention—because no baby should be lost to preeclampsia. ...

MirZyme announced today that it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health...